Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion type Assertion NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_head.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion evidence source_evidence_literature NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion SIO_000772 20358631 NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion wasDerivedFrom befree-20150227 NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.
- NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_assertion wasGeneratedBy ECO_0000203 NP527355.RAkQ6DY2RCtKGV_mr8zcOoym0m4ACAXpjFXx-r3pXC-Nc130_provenance.